- About diabetes
- Who we are
- Network
- Activities
- E-Library
- News
- Events
- You are here:
-
Home
-
Activities
-
Education
-
KIDS
- Our network
- Details
- Written by Margaux
- Category: Our network
- Hits: 3174
In April-May 2020, IDF held a consultation with its networks, including the Blue Circle Voices (BCV), with the aim of learning more about the smoking habits of people living with diabetes and their perspective on tobacco. 178 people responded to the survey.
Key findings included:
- 81% of respondents who used to smoke indicated having noticed an improvement in their health after stopping smoking.
- 80% of respondents were aware that smoking is among the risk factors for type 2 diabetes and can have an impact on the management and control of all types of diabetes.
- 63% of respondents who currently smoke indicated that they were never offered support from a health professional to stop smoking.
- 58% of respondents who currently smoke indicated that smoking did not have any negative impact on their health.
- A majority of respondents searched for information on the link between diabetes and tobacco on their own.
- 48% of respondents who used to smoke indicated that their diabetes diagnosis influenced their decision to stop smoking.
- 39% of respondents who currently smoke indicated the main reason why they did not stop smoking was because they did not want to
Click on the image to download the full results in pdf.
- Details
- Written by IDF
- Category: Our network
- Hits: 3164
In October 2018, IDF held a consultation with its networks, including the Blue Circle Voices (BCV), with the objective of gathering their views on the UN HLM Political Declaration and IDF's preliminary statement. Some 78 participants responded to the survey.
More than 91% of them fully supported the statement.
Learn more about IDF's networks' views on the matter by downloading the highlights report. - Details
- Written by Lorenzo Piemonte
- Category: Our network
- Hits: 38606
88 million adults (20-79) are living with diabetes in the IDF South-East Asia (SEA) Region in 2019. This figure is estimated to increase to 153 million by 2045.- Over half of people with diabetes (57%) in the IDF SEA Region are undiagnosed.
- Diabetes was responsible for 1.2 million deaths in the IDF SEA Region in 2019.
- 1 in 4 live births in the IDF SEA Region are affected by hyperglycaemia in pregnancy.
- USD 8.1 billion was spent on healthcare for people with diabetes in 2019— the second lowest expenditure of all IDF regions.
Source: IDF Diabetes Atlas 9th Edition 2019Diabetes and cardiovascular disease (CVD)
People with diabetes are at increased risk of developing cardiovascular disease (CVD). CVD is a major cause of death and disability in people with diabetes, and a barrier to sustainable development.In 2017, the International Diabetes Federation (IDF), in partnership with Novo Nordisk, initiated the Taking Diabetes to Heart study to assess knowledge and awareness of CVD among people with type 2 diabetes. Data was collected between September 2017 and May 2018 through an online questionnaire in 32 languages. A total of 12,695 participants from 133 countries across all seven IDF regions took part in the study. The questionnaire comprised 17 questions divided into the following sections: demographics; CVD risk knowledge; CVD risk awareness; education on CVD by health professionals; and CVD information sources.
929 responses were received from the IDF South-East Asia Region. Download the findings (pdf).
- Details
- Written by Lorenzo Piemonte
- Category: Our network
- Hits: 34909
163 million adults (20-79) are living with diabetes in the IDF Western Pacific Region in 2019. This figure is estimated to increase to 212 million by 2045.- The IDF Western Pacific Region is home to 35% of all people living with diabetes worldwide.
- Over half of people with diabetes (56%) in the IDF Western Pacific Region are undiagnosed.
- Diabetes was responsible for 1.3 million deaths in the IDF Western Pacific Region in 2019 — the highest number of deaths due to diabetes of all IDF regions.
- 1 in 8 live births in the IDF Western Pacific Region are affected by hyperglycaemia in pregnancy.
- USD 162 billion was spent on healthcare for people with diabetes in 2019— 14% of the total global health expenditure on diabetes.
Source: IDF Diabetes Atlas 9th Edition 2019Diabetes and cardiovascular disease (CVD)
People with diabetes are at increased risk of developing cardiovascular disease (CVD). CVD is a major cause of death and disability in people with diabetes, and a barrier to sustainable development.In 2017, the International Diabetes Federation (IDF), in partnership with Novo Nordisk, initiated the Taking Diabetes to Heart study to assess knowledge and awareness of CVD among people with type 2 diabetes. Data was collected between September 2017 and May 2018 through an online questionnaire in 32 languages. A total of 12,695 participants from 133 countries across all seven IDF regions took part in the study. The questionnaire comprised 17 questions divided into the following sections: demographics; CVD risk knowledge; CVD risk awareness; education on CVD by health professionals; and CVD information sources.
4219 responses were received from the IDF Western Pacific Region. Download the findings (pdf).
- Details
- Written by Lorenzo Piemonte
- Category: Our network
- Hits: 26574
32 million adults (20-79) are living with diabetes in the IDF SACA Region in 2019. This figure is estimated to increase to 49 million by 2045.- 42% of people living with diabetes in the IDF SACA Region are undiagnosed.
- Diabetes is responsible for 243,000 deaths in the IDF SACA Region in 2019.
- 34 million adults (20-79) in the IDF SACA Region have Impaired Glucose Tolerance (IGT), which places them at high risk of developing type 2 diabetes.
- 1 in 7 live births in the IDF SACA Region are affected by hyperglycaemia in pregnancy.
- USD 70 billion was spent on healthcare for people with diabetes in 2019 — 9% of total global expenditure on diabetes.
Source: IDF Diabetes Atlas 9th Edition 2019Diabetes and cardiovascular disease (CVD)
People with diabetes are at increased risk of developing cardiovascular disease (CVD). CVD is a major cause of death and disability in people with diabetes, and a barrier to sustainable development.In 2017, the International Diabetes Federation (IDF), in partnership with Novo Nordisk, initiated the Taking Diabetes to Heart study to assess knowledge and awareness of CVD among people with type 2 diabetes. Data was collected between September 2017 and May 2018 through an online questionnaire in 32 languages. A total of 12,695 participants from 133 countries across all seven IDF regions took part in the study. The questionnaire comprised 17 questions divided into the following sections: demographics; CVD risk knowledge; CVD risk awareness; education on CVD by health professionals; and CVD information sources.
936 responses were received from the IDF South and Central America region. Download the findings (pdf).
- Who we are
